Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,500 shares at $77.06 ($581K) on 2013-08-15, disclosed to the SEC on 2013-08-19.
Scheduled sale ($581k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.06 | 4,500 | $347K | 59.7% |
| 2 | $77.93 | 3,000 | $234K | 40.3% |
| Total | $77.41 avg | 7,500 | $581K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |